Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets

Á Nagy, A Lánczky, O Menyhárt, B Győrffy - Scientific reports, 2018 - nature.com
Multiple studies suggested using different miRNAs as biomarkers for prognosis of
hepatocellular carcinoma (HCC). We aimed to assemble a miRNA expression database …

[HTML][HTML] Guidelines for the selection of functional assays to evaluate the hallmarks of cancer

O Menyhárt, H Harami-Papp, S Sukumar… - … et Biophysica Acta (BBA …, 2016 - Elsevier
The hallmarks of cancer capture the most essential phenotypic characteristics of malignant
transformation and progression. Although numerous factors involved in this multi-step …

Comprehensive review of web servers and bioinformatics tools for cancer prognosis analysis

H Zheng, G Zhang, L Zhang, Q Wang, H Li… - Frontiers in …, 2020 - frontiersin.org
Prognostic biomarkers are of great significance to predict the outcome of patients with
cancer, to guide the clinical treatments, to elucidate tumorigenesis mechanisms, and offer …

[HTML][HTML] Epigenetic and breast cancer therapy: promising diagnostic and therapeutic applications

G Sher, NA Salman, AQ Khan, KS Prabhu… - Seminars in cancer …, 2022 - Elsevier
The global burden of breast cancer (BC) is increasing significantly. This trend is caused by
several factors such as late diagnosis, limited treatment options for certain BC subtypes …

Epigenetics of SFRP1: The Dual Roles in Human Cancers

R Baharudin, FYF Tieng, LH Lee, NS Ab Mutalib - Cancers, 2020 - mdpi.com
Secreted frizzled-related protein 1 (SFRP1) is a gene that belongs to the secreted
glycoprotein SFRP family. SFRP1 has been classified as a tumor suppressor gene due to …

Autoantibodies as biomarkers for breast cancer diagnosis and prognosis

R Yang, Y Han, W Yi, Q Long - Frontiers in Immunology, 2022 - frontiersin.org
Breast cancer is the most common cancer in women worldwide and is a substantial public
health problem. Screening for breast cancer mainly relies on mammography, which leads to …

DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma

G Kerdivel, F Amrouche, MA Calmejane, F Carallis… - Clinical …, 2023 - Springer
Background Adrenocortical carcinoma is rare and aggressive endocrine cancer of the
adrenal gland. Within adrenocortical carcinoma, a recently described subtype characterized …

Immune surveillance in clinical regression of preinvasive squamous cell lung cancer

A Pennycuick, VH Teixeira, K AbdulJabbar, SEA Raza… - Cancer discovery, 2020 - AACR
Before squamous cell lung cancer develops, precancerous lesions can be found in the
airways. From longitudinal monitoring, we know that only half of such lesions become …

Association of BRCA1 promoter methylation with sporadic breast cancers: Evidence from 40 studies

L Zhang, X Long - Scientific reports, 2015 - nature.com
Breast cancer susceptibility gene 1 (BRCA1) located at chromosome 17q12-21 is a classic
tumor suppressor gene and has been considered as a significant role in hereditary breast …

[HTML][HTML] Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer

L Qi, B Zhou, J Chen, W Hu, R Bai, C Ye… - Journal of …, 2019 - ncbi.nlm.nih.gov
Introduction: Abnormal status of gene expression plays an important role in tumorigenesis,
progression and metastasis of breast cancer. Mechanisms of gene silence or activation were …